 
 
GtoPdb is requesting financial support from commercial users. Please see our sustainability page for more information.
| Compound class: 
                                                            Synthetic organic
                                 
                                    
                                        Comment: Chinfloxacin is a synthetic tricyclic fluoroquinolone antibacterial [1]. Its chemical structure is similar to that of moxifloxacin.
                                    
                                 | 
 | |||||||||||||||||||||||||||||||||||
| No information available. | 
| Summary of Clinical Use  | 
| Chinfloxacin completed first-in-human trial in healthy subjects with results published in 2018 [2]. Its pharmacokinetics supported once-daily dosing. |